STOK
Stoke Therapeutics, Inc.
Key Financials
Operating Income
$-20590000
↑ 79.7%
Cash & Equivalents
$84.2M
↓ 34.2%
Total Assets
$418.4M
↑ 54.1%
Net Income
$-6885000
↑ 92.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STOK |
| Company Name | Stoke Therapeutics, Inc. |
| CIK | 1623526 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-430-8200 |